These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 32460771)

  • 1. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance.
    Yuan L; Xu ZY; Ruan SM; Mo S; Qin JJ; Cheng XD
    Mol Cancer; 2020 May; 19(1):96. PubMed ID: 32460771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
    Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
    J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs underlying chemoresistance in gastric cancer.
    Poursheikhani A; Bahmanpour Z; Razmara E; Mashouri L; Taheri M; Morshedi Rad D; Yousefi H; Bitaraf A; Babashah S
    Cell Oncol (Dordr); 2020 Dec; 43(6):961-988. PubMed ID: 32495294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs in anti-cancer drug resistance.
    Chen QN; Wei CC; Wang ZX; Sun M
    Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
    Matuszcak C; Haier J; Hummel R; Lindner K
    World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs in gastric cancer.
    Xie S; Chang Y; Jin H; Yang F; Xu Y; Yan X; Lin A; Shu Q; Zhou T
    Cancer Lett; 2020 Nov; 493():55-70. PubMed ID: 32712234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
    Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
    World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
    Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
    Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications.
    Meng X; Bai X; Ke A; Li K; Lei Y; Ding S; Dai D
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
    Lin Z; Lu S; Xie X; Yi X; Huang H
    Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-induced drug resistance in gastric cancer.
    Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
    Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs in regulating gastric cancer metastasis.
    Feng W; Ding Y; Zong W; Ju S
    Clin Chim Acta; 2019 Sep; 496():125-133. PubMed ID: 31276633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel biomarkers for the identification and targeted therapy of gastric cancer.
    Liu L; Cao L; Gong B; Yu J
    Expert Rev Gastroenterol Hepatol; 2015; 9(9):1217-26. PubMed ID: 26220043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs in drug resistance of head and neck cancers: A review.
    Dai F; Dai L; Zheng X; Guo Y; Zhang Y; Niu M; Lu Y; Li H; Hou R; Zhang Y; Wen S; Hu W; An C; Wu Y; Gao W
    Biomed Pharmacother; 2020 Jul; 127():110231. PubMed ID: 32428836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer.
    Sun W; Jiang C; Ji Y; Xiao C; Song H
    Biomed Res Int; 2021; 2021():8853269. PubMed ID: 33506041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.